Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 02 Jun 2017 Planned End Date changed from 1 Apr 2018 to 10 May 2018.
- 02 Jun 2017 Planned primary completion date changed from 1 Oct 2017 to 10 May 2017.